Showing posts with label Pharma Marketing News. Show all posts
Showing posts with label Pharma Marketing News. Show all posts

Friday, October 5, 2007

'Round the Sphere/Week in Review: Let's Party!


From the looks of things, we are ALL working too hard! We need a party! And I don't mean a virtual party.

I'm trying to organize a real life Halloween party in my neck of the woods (Newtown, PA).

Here's the map:


View Larger Map

There are many pharma-related businesses right here in Newtown. Of course, the Pharma Marketing Network/News empire is located here.

PharmaLive/Engel Publishing, which brings us Pharma Blogs: Week in Review written by Christiane Truelove, is also in Newtown. Would you believe I am in walking distance of their offices and have never met Christiane. I've probably seen her crossing Newtown-Yardley Road to get lunch at the deli -- Watch Out! I don't break for competitors!

It was actually Christiane that gave me the idea for a party -- she's obviously been working very hard and wasn't able to get out her newsletter for the last couple of weeks! But it's back today! Here's an excerpt:

On Thursday, Dr. Daniel Carlat testified at the Massachusetts State House on a bill to control health-care costs in Massachusetts. One part of the bill would ban most drug company gifts to doctors. Dr. Carlat shared with readers an incident that happened to him, when a rep’s gift influenced his prescribing decision. “The fact is that pharmaceutical gifting is an effective marketing technique, as much as physicians deny that their medical opinions can be swayed by such small dispensations,” Dr. Carlat says.

Speaking of gifts, John Mack of the Pharmaceutical Marketing Blog talks about the mixed messages from Lilly in offering a paper-sorting tray to Cymbalta-prescribing physicians. While Mr. Taurel was urging the health-care industry to go to electronic records, Lilly’s mailer for Cymbalta was proclaiming that the paperless office is a myth and offering the letter tray to help keep physicians’ offices organized. “But the story is more than the left hand not knowing what the right hand is doing,” Mr. Mack says. “It's about drug safety and Lilly's lip service to drug safety.” Apparently these mailers were cited by FDA for making misleading efficacy claims and understating risk. Mr. Mack posts a story done by the Wall Street Journal here. “Perhaps Lilly and FDA need to go paperless in order to achieve better, more efficient communications so that they can understand one another,” Mr. Mack says.

And speaking of online electronic health records in the quest for the paperless office, Merrill Goozner of GoozNews talks about how Microsoft has unleashed its PR blitz for the Microsoft Health Vault, which would allow consumers to generate online personal health records. Mr. Goozner dissects a quote from Microsoft CEO Bill Gates in the Wall Street Journal, in which Mr. Gates points out that almost all test results, prescriptions, procedures, etc. are already recorded in digital form. “So, then, isn't it a simple task to insist that these electronic medical records be made available upon request to patients and other physicians (with patient approval)?” Mr. Goozner wonders. “Isn't it a simple task to pass a law that requires all physicians, hospitals and clinics transition to patient-available electronic medical records with portability if they wish to continue collecting fees from Medicare, Medicaid and other government programs, which account for nearly half of all direct health care expenditures?” He does concede that there will be interoperability and data-reporting standards that would have to be resolved. I think interoperability issues would be a significant problem — if you’ve ever had the joyous task of transferring files between an old home computer to a new model, you can imagine how much more of a nightmare is involved when putting together a system whose files can be easily transferred between the physician, health insurance company, and consumer. Thus, Microsoft is designing a system in which Mr. Gates says the patient can be the center and can decide who to share the health data with.

Mr. Mack is not too enthusiastic about the Health Vault offering. “Anyway, why would you entrust your personal health information with a technology company known to be prone to privacy and security lapses?” he wonders. “Wouldn't it make more sense to go with a service from a company with healthcare experience like Aetna or Wellpoint? While you may not trust health insurance companies, at least these companies must comply with health information privacy and security standards set by HIPAA and they have a good incentive to protect their clients' privacy — unlike Microsoft, their business depends upon it.”
As for the party -- let me know if you can make it. Costumes required -- I am sure we can get some ideas on what costume suits each of us from Pharma Giles!

Wednesday, August 22, 2007

'Round the Sphere: China, TV Ads, and Malls

Wow! The Blogger servers were down over one hour this morning, right after I posted about FDA testing TV ads in malls across the USA (see "FDA at a Mall Near You: The Manchurian Connection") and after sending an email notice to thousands of my subscribers notifying them of the new post. Talk about bad timing!

BTW, if you are a subscriber, I love you! I really do!

Other bloggers in the Pharma Blogosphere had comments about the proposed FDA survey of consumers.

Ed Silverman over at Pharmalot, for example. gave the details as revealed by the FDA in the federal register -- a wonderful book, BTW; not too much murder or mayhem.

Ed, who may not believe in coincidences, questioned whether the announcement was in reaction to "a study in The New England Journal of Medicine [that] found that FDA policing of advertising has declined steadily in recent years." (See "FDA Will Examine Those Upbeat TV Ads").

Sorry to disappoint the conspiracy theorists out there, but the FDA has proposed and may have even conducted a number of these "mall intercept" studies. I point this out in my blog over there at Pharma Marketing Blog (did I already mention my post to Pharma Marketing Blog on this topic? Yes? No? OK, here it is.)

Jacob Goldstein over at The WSJ Health Blog introduced the topic this way:

"A lithe woman dances her way through a field of flowers, or whatever. Maybe her hair’s blowing in the wind. She’s definitely smiling–a lot. Meanwhile, the monotone voiceover tells you about horrible things like diarrhea, swelling and heart disease. So what’s the real message about the drug being advertised–the woman’s winning smile or the announcer’s warning?" (See "The Pictures Are Happy, the Words Are a Bummer").
Other, less imaginative bloggers in the Sphere (who will remain nameless), came late to the game and more or less re-iterated what Ed already said about the link between the NEJM study and the FDA study. At least one of these other bloggers got the basic information wrong and reported that 2,000 people would be studied when actually only 1,020 will be surveyed (2,000 will be screened, but not all of them surveyed). Small point, but good journalists -- like Ed and Jacob -- get their facts straight!

But no blogger, other than myself that is, made the connection between this proposed study and China.

What caught my attention in the FDA announcement was that no-one who was able to read Chinese would be included in the study.

Whaaa! Is this racial discrimination? Has some law of the land been broken? Why exclude Chinese citizens over the age of 40, all of whom I assume read Chinese?

I am not going to reveal the reason for this here or how recent news about China imports come into the picture. You'll have to read my post over there at Pharma Marketing Blog to find out.

BTW, another story I linked to the FDA announcement was the one that was written up in the Newark Star Ledger and summarized by -- guess who! -- Ed Silverman over at Pharmalot, which is owned by -- guess who! -- the Newark Star Ledger (not that there's anything wrong with that!).

That story was about the measurement of saccadic eye motion, which provides a kind of window into subliminal thoughts (see "Drug Ads Are Ignored In The Blink Of An Eye").

Of course, I had already interviewed Lee Weinblatt, the inventor of the technology used to measure saccadic eye motion in subjects viewing print and TV DTC ads, in a July 25, 2007 Pharma Marketing Talk podcast (listen to it here -- it's quite entertaining and educational).

And I first published a synopsis of the technology in my FREE Pharma Marketing News e-newsletter (see "Stop Wasting $Millions on Ineffective DTC Ads!").

Order the Full Article Reprint - $6.95

Or you can subscribe to the newsletter and get it free!

Here's an unbiased review of my newsletter by my publisher:
"Each issue of Pharma Marketing News is packed with facts, opinions, and case studies based upon interviews with experts in the field of pharmaceutical marketing. Highlights of presentations from industry conferences, contact lists for experts consulted, and links to references help subscribers keep up to date on best practices and network with their peers." -- John Mack, Publisher
I also have T-shirts, cups, mouse mats, pens, etc. with the Pharma Marketing News logo and "Question Everything" slogan on them.

Tuesday, August 21, 2007

Record Number of New Subscribers Anxious to Read My Review of Killer Drug!

Thanks to some free promotion from spinmeister Peter Rost, a record number of new subscribers have signed up to receive their free issue of Pharma Marketing News.

This month's issue, which will hit the eStands at 8:00 AM this morning (subscribers only) features a review of Rost's new book Killer Drug plus the novel, Big Pharma.

Contributing to these reviews are the following bloggers:

The subscription is free: SUBSCRIBE HERE and get this issue delivered to you FREE!

See a synopsis of this month's issue: August Issue of Pharma Marketing News: Wasting Money on DTC, Time to Rethink How to Engage Physicians, Whistleblower Novels

As you can see, it's not all about Rost!

Thursday, June 28, 2007

Moore, You Magnificent Bastard! I Read Your "Book!" But Did You?

Michael Moore is giving PR lessons to would-be promoters of screenings of his new movie SiCKO. See his "Sponsor a 'SiCKO' Screening" Web page.

Here's one bit of advice offered there about "HOW TO GET PRESS":

When the press arrives at the event, make sure one person on your team greets each reporter and remains available for their requests.
Makes sense.

But let's compare this to how I was treated at my screening of SiCKO a couple of weeks ago in NYC (see "John Mack Finally Gets His SiCKO Screening: You Can Too!").

When I arrive, there is one person who merely checks my name off a list and hands me a couple of sheets of info. After the screening, when I would likely have a number of questions -- including "Where's the bathroom?" -- there's nobody there! I have to ask the projectionist who was startled that anyone would walk into the projection both and actually speak to him! In any case, he did give me the key code to the men's room.

I must say, I was impressed! NOT!

But I wrote the story anyway and you can read it in the June issue of Pharma Marketing News (subscription required; it's FREE!).

Monday, May 7, 2007

Love it, Truly!

Chris Truelove has man handled me over in the comments to my Pharma Marketing News post "Guidelines for Gifts to Patients" and suggested that my "casting the verbal disagreement between Dr. Black Kitty and me as a 'Kitty fight,' you've implied a bimbo-tastic tone that's hard for folks to get past and take us seriously. It's an attitude that is satired in this classic Harry Enfield piece:"



Yes, that husband could be me! It happens every time my wife and I attend a dinner party! If only I had seen this a long time ago, I'm sure I'd be more happily married.

In my defense:

At least I refrained from posting any R-rated images of women, which is becomming more common amongst pharma bloggers, especially those who emulate Peter Rost and PharmaGossip! Speaking of whom, did you see the image PharmaGossip used to illustrate Truelove's story about a sales rep who stripped down to her bikini in a doc's office?

In defense of my male colleagues (ie, Peter Rost and Jack Friday), if you put meat in front of lions, you've got to expect them to feast! In other words, Truelove could have chosen not to describe the bikini rep incident, since it is anecdotal anyway and does no good for the image of women reps.

Thursday, April 26, 2007

Free Reprints: Pharma Blogosphere Survey Results, YouPharma

I just published the April 2007 issue of Pharma Marketing News, which includes two article that I know will be of interest to Pharma BlogosphereTM members and readers of this blog in general.

To receive free reprints (pdf files) of these articles by email, please fill out the online Reprint Request Form. This offer is avaiable ONLY through midnight (Eastern US) Saturday, April 28, 2007.

If you are one of my pharma blogger compadres who doesn't have time for no stinkin' forms and wants the survey results as soon as possible, you may send me an email (you know it!).

Note: I appreciate a discussion of the survey results and realize that I cannot make everyone happy. If you are going to complain and bitch about it on your blogs, you might wait until you can discuss it with me. Keep in mind that I worked with a market research specialist who set up the conditions for filtering the results and who prepared most of the charts. I have learned a lot by doing this and know there are limitations. Hopefully, with constructive criticism I can improve it for the next go round.


The articles are:

How Readable, Credible & Useful are Pharma Blogs?

This article presents the complete results from the first ever survey of The Pharma Blogosphere in which blog readers evaluate 22 different pharma-related blogs on the basis of readability, credibility, usefulness, and bias.

Topics and issues covered include:

  • Frequency of Reading
  • Is It a Legitimate Issue?
  • Bias: Industry Critics vs Industry Supporters
  • Readability, Credibility, and Usefulness
  • The TOP FIVE Overall Honors
  • Industry vs. Non-Industry Readers
  • Blogs and Readers of a Feather Flock Together

Charts and Tables include:

  • FIGURE 1: Frequency of Reading
  • FIGURE 2: "Industry Critics"
  • FIGURE 3: "Industry Supporters"
  • FIGURE 4: Overall Honors, ranked by credibility
  • TABLE 1A: TOP FIVE Readable blogs (overall)
  • TABLE 1B: TOP FIVE Credible blogs (overall)
  • TABLE 1C: TOP FIVE Useful blogs (overall)
  • TABLE 2A: TOP FIVE Readable blogs, industry respondents vs. non-industry respondents
  • TABLE 2B: TOP FIVE Credible blogs, industry respondents vs. non-industry respondents
  • TABLE 2A: TOP FIVE Useful blogs, industry respondents vs. non-industry respondents


YouPharma: New Rules for Pharma Marketing and Social Media

The return on investments for traditional pharma marketing channels -- TV, drug reps, print -- is declining. A new approach to the way forward in pharma marketing is needed. Is it time for the pharmaceutical industry to take the advice of some of its critics and use the new Web 2.0 tools available to it and extricate itself from its moribund situation of declining ROI? Highlights from a Pharma Roundtable discussion and comments from several bloggers in the Pharma Blogosphere.

Topics and issues covered include:

  • DTC Spending Up, ROI Down
  • Fard Johnmar's Web 2.0 Tools Sampling
  • Some Pharma Feet Are Getting Wet
  • Employee Blogs
  • Code of Conduct
  • YouPharma: It's Not About Us, It's About Them
  • Put Some Skin in the Game\
  • Beating the Pros